Sign In Join

hgm2018 logo


APR 24-26, 2019 | SEOUL, SOUTH KOREA

Supporting Partners

Avatar Ewha Womans University is co-hosting Human Genome Meeting 2019 with Human Genome Organization.
Avatar The Human Variome Project is an international non-governmental organisation that is working to ensure that all information on genetic variation and its effect on human health can be collected, curated, interpreted and shared freely and openly. The Human Variome Project provides a central coordinating function for national and international efforts to integrate the collection, curation, interpretation, and sharing of information on variation in the human genome into routine clinical practice and research. We are an active and growing Consortium of over 1,100 individual researchers, healthcare professionals, policy makers, and organisations from 81 countries that collaborate to develop and maintain the necessary standards, systems and infrastructure to support global-scale genomic knowledge sharing. The Project itself is not directly involved in the development and operation of physical data storage and sharing infrastructure; that is the responsibility of international disease groups, national consortia/health systems and individual members.
Chen Award Supporter

Professor Yuan-Tsong (Y-T) Chen and Mrs. Alice Der-Shan Chen were both originally from Taiwan and have been committed to biomedical research for over 30 years. They recognise the tremendous impact that genetics and genomics have had on the improvement of health and treatment of diseases and wish to establish the Chen Award to celebrate research accomplishments in Human Genetics and Genomics in Asia Pacific. Professor Chen received his MD degree from National Taiwan University (Taipei) and a PhD from Columbia University (USA). He is currently a Distinguished Research Fellow and Director of the Institute of Biomedical Sciences, Academia Sinica, Taiwan, and Professor of Pediatrics and Genetics at Duke University Medical Center (USA).

Professor Chen is a physician/scientist, recognised for his work on human genetic disorders. His translational research leads to the development of now standard therapies for two devastating inherited metabolic diseases: a simple and effective cornstarch therapy for severe hypoglycemia in glycogen storage diseases and an enzyme replacement therapy, the first ever treatment, for a debilitating, progressive and often fatal myopathy called Pompe disease. Professor Chen has also identified the genetic basis of and developed DNA-based diagnosis for several major heritable diseases, and more recently, his team in Taiwan has uncovered genes/SNPs associated with drug-induced Stevens-Johnson syndrome and warfarin sensitivity.

His latest pharmacogenomic studies of adverse drug reactions paved the way for personalised medicine by preventing drug toxicity with a gene test. Professor Chen is an elected member of Academia Sinica and of the Academy Sciences for the Developing World.

HUGO African Prize Supporter

inqaba biotec™ is a unique South African Genomics company. inqaba biotec™ is a provider of products in Life Sciences and Molecular Diagnostics as well as services such as Next generation DNA sequencing, SNP analysis, Methylation analysis, Bioinformatics support, Medical genomics analysis, Surgimaggs (sterile medical wound cleaning maggots) and many more.

Thermo Fisher Scientific is the world leader in serving science, with revenues of more than $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands ? Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services ? we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, is committed to enabling effective and affordable healthcare solutions for all. Based on its proprietary technology, MGI produces sequencing devices, equipment, consumables and reagents to support life science research, medicine and healthcare. MGI’s multi-omics platforms include genetic sequencing, mass spectrometry and medical imaging. Providing real-time, comprehensive, life-long solutions, its mission is to develop and promote advanced life science tools for future 바이오니아는 1992년 바이오 벤처 1호 기업으로서, 혁신과 가치창조를 기업정신으로 삼아  끊임없는 연구개발을 통해 유전자분야에 필수적인 첨단시약과 장비들을 개발, 보급하여 왔습니다. 이런 핵심 인프라를 기반으로 분자진단 제품, 난치병 치료제 및 혁신적인 고부가가치 제품 개발을 통해 인류의 건강을 증진시키는 기업을 목표로 끊임없이 연구하는 회사입니다. FUJIFILM Irvine Scientific has been at the forefront of cell culture media development for more than 45-years. Possessing an unrivaled heritage of innovation, superior quality, and technical expertise, the company supplies the cytogenetic, immunotherapy, biopharmaceutical, cell therapy, and Assisted Reproductive Technologies (ART) industries with a range of advanced cell culture media products and expert development, optimization, and commercial manufacturing services. Through the CHANG® Medium platform of cytogenetic media, Irvine Scientific offers a complete line of cytogenetic media solutions to support prenatal, postnatal, and diagnostic needs.